King Guide Logo

Online Edition
Desktop, Tablet or Phone


Spring 2024

In this update we added a new monograph for REMDESIVIR.

We also added new stability information to the monographs for EPINEPHRINE HYDROCHLORIDE and REMDESIVIR.

New compatibility information was added to the existing drug monograph FOR ALPROSTADIL, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BUMETANIDE, CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, MORPHINE SULFATE, OCTREOTIDE ACETATE, PIPERACILLIN AND TAZOBACTAM, SILDENAFIL CITRATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN.

Improve Your IV Drug Information

To have the most complete information possible ASHP recommends multiple sources of IV drug information be available to hospital pharmacy. The King® Guide has been updated quarterly since 1971 and is an excellent addition to any drug information library with complete monographs for over 600 injectable drugs.

Features

  • Exceeds TJC Requirements
  • NABP Endorsed
  • Over 600 IV drugs with at-a-glance view of compatibility in 12 fluids
  • Over 3,200 primary source references
  • Includes routes, dosages, temperatures, and containers used to determine compatibility and stability.
  • Y-Site, Syringe, and other sets/container specific information.
  • Extensive TPN/TNA data.
  • Special Sections on Stability and Storage
  • Boxed Warning and Hazardous Drugs List and Identification
  • Proprietary and Generic Drug Names Included

Drug Shortages Demand Additional Information

The ongoing shortage of drugs, and especially small volume parenteral solutions, is causing changes in methods of drug administration. The King Guide® to Parenteral Admixtures® is designed to help practitioners decide which alternative administration strategy is best.

Switching to IV push, using solutions other than saline, using large volume solutions, or using syringe infusion pumps, may change the stability and compatibility characteristics of the medication to be administered. Fortunately, King® Guide, the oldest continuously published reference on parenteral drug stability and compatibility, is designed to provide practitioners with the timely information they need in this era of drug shortages.

In Hospital Pharmacy

The online edition started as a direct replacement for the original loose-leaf King Guide. Today hospital pharmacists have access to the entire King Guide in the pharmacy, at nurses stations, on-rounds, on-call at home, on tablets and phones - all with the same user interface and no software to install or maintain.

Authoritative Information

The King® Guide to Parenteral Admixtures® exceeds TJC requirements for updated references, is NABP endorsed and listed by name by many state pharmacy boards as a required reference.

Easy to Use

From a single drug to multiple drugs is shown in a clear easy to read format. Search fields self-populate with brand and generic drug names as you type, and compatibility results are instantly generated as you build your drug list.

No Software to Install or Maintain

With no software to install and no updates to apply practitioners are assured of having the latest and most up-to-date information available.  For added convenience, subscribers can login with an ip address and bypass the login screen.

Flexible Licensing

The King Guide is available everywhere, so we designed our subscriptions to be flexible. All subscriptions provide for access from any computer, tablet or phone. The single user license allows access from any computer or device from any location and limits access to one person at a time while the site license allows access from an unlimited number of computers or devices. A separate license is required for each facility location and we offer discounts for multiple licenses.


Ready to Order?


Buy Now  Purchase Order 

Have Questions?

View answers to our most frequently asked question

Documentation Contact Us

Stay Informed Of Drugs With New Information
Join Our Newsletter